#preclinical studies

1 story

#ai #ai-designed #immorta bio #immune cells #senescent cells #senolytic peptide #technology

Immorta Bio finishes AI senolytic peptide trials
Immorta Bio completes preclinical studies for AI-designed senolytic peptide.
RuntimeWire · 1m